Literature DB >> 19744432

Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer.

Ugo Boggi1, Marco Del Chiaro, Chiara Croce, Fabio Vistoli, Stefano Signori, Carlo Moretto, Gabriella Amorese, Salvatore Mazzeo, Carla Cappelli, Daniela Campani, Franco Mosca.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the operative risk and the prognostic implications of pancreatectomy plus resection and reconstruction of peripancreatic vessels (PPV) in patients with pancreatic adenocarcinoma.
METHODS: One hundred ten patients who underwent pancreatectomy with PPV resection and reconstruction (Study Group; SG) were retrospectively compared with 62 patients without distant metastasis who were palliated, (Control Group 1; CG-1), as well as 197 patients who underwent "conventional"pancreatectomy (Control Group 2; CG-2).
RESULTS: Postoperative morbidity and mortality were similar in SG (33% and 3%), in CG-1 (26% and 3%), and in CG-2 (40% and 6%) patients. Median survival time (MST) of SG patients (15 months) was longer than that of CG-1 patients (6 months; P < .0001) and similar to that of CG-2 patients (18 months). Patients undergoing isolated venous resection (n = 84) had the best outcome (MST: 15 months) ( P < .0001 vs CG-1 patients), while patients undergoing resection of multiple PPV (n = 14) had the worst outcome (MST: 8 months). PPV infiltration, histologically proven in 64 patients (65%), was associated with decreased MST only if the tunica intima was infiltrated (26%) (11 months; P < .001). Multivariate analysis showed that no adjuvant therapy, intimal invasion, and poorly differentiated histology were associated with a higher hazard of death by 2.2, 2.2, and 2.5-fold, respectively.
CONCLUSION: In properly selected patients, pancreatectomy plus resection and reconstruction of PPV was performed as safely as palliation or "conventional" pancreatectomy and was associated with better survival when compared to palliation.

Entities:  

Mesh:

Year:  2009        PMID: 19744432     DOI: 10.1016/j.surg.2009.04.029

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  30 in total

1.  Laparoscopic robot-assisted versus open total pancreatectomy: a case-matched study.

Authors:  Ugo Boggi; Simona Palladino; Gabriele Massimetti; Fabio Vistoli; Fabio Caniglia; Nelide De Lio; Vittorio Perrone; Linda Barbarello; Mario Belluomini; Stefano Signori; Gabriella Amorese; Franco Mosca
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

Review 2.  Prognostic factors related with survival in patients with pancreatic adenocarcinoma.

Authors:  Ahmet Bilici
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  An Improved Staging System for Locally Advanced Pancreatic Cancer: A Critical Need in the Multidisciplinary Era.

Authors:  Marc W Fromer; Jenci Hawthorne; Prejesh Philips; Michael E Egger; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  Ann Surg Oncol       Date:  2021-06-04       Impact factor: 5.344

4.  A propensity score-matched analysis of robotic versus open pancreatoduodenectomy for pancreatic cancer based on margin status.

Authors:  Emanuele F Kauffmann; Niccolò Napoli; Francesca Menonna; Sara Iacopi; Carlo Lombardo; Juri Bernardini; Gabriella Amorese; Andrea Cacciato Insilla; Niccola Funel; Daniela Campani; Carla Cappelli; Davide Caramella; Ugo Boggi
Journal:  Surg Endosc       Date:  2018-06-25       Impact factor: 4.584

5.  Is there a role for arterial reconstruction in surgery for pancreatic cancer?

Authors:  Reena Ravikumar; David Holroyd; Giuseppe Fusai
Journal:  World J Gastrointest Surg       Date:  2013-03-27

6.  Arterial resection for pancreatic cancer: a modern surgeon should change its behavior according to the new therapeutic options.

Authors:  E Vincente; Y Quijano; B Ielpo
Journal:  G Chir       Date:  2014 Jan-Feb

7.  Recent advances and limitations of surgical treatment for pancreatic cancer.

Authors:  Keiichi Kubota
Journal:  World J Clin Oncol       Date:  2011-05-10

8.  Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study.

Authors:  Federico Selvaggi; Giuseppe Mascetta; Despoina Daskalaki; Marco dal Molin; Roberto Salvia; Giovanni Butturini; Carlo Cellini; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2014-04-30       Impact factor: 3.445

9.  Resection or repair of large peripancreatic arteries during robotic pancreatectomy.

Authors:  Emanuele F Kauffmann; Niccolò Napoli; Concetta Cacace; Francesca Menonna; Fabio Vistoli; Gabriella Amorese; Ugo Boggi
Journal:  Updates Surg       Date:  2020-02-18

10.  Cold-stored cadaveric venous allograft for superior mesenteric/portal vein reconstruction during pancreatic surgery.

Authors:  Dyre Kleive; Audun E Berstad; Caroline S Verbeke; Sven P Haugvik; Ivar P Gladhaug; Pål-Dag Line; Knut J Labori
Journal:  HPB (Oxford)       Date:  2016-06-20       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.